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Introduction : 
Depuis plus de 50 ans, les fistules artérioveineuses radiocéphaliques {FAV} restent le meilleur accès 
d'hémodialyse en termes de perméabilité et de complications. Néanmoins, l'échec précoce dû aux 
thromboses ou à la non maturation entraîne leur abandon chez un nombre significatif de patients. 
Cette étude prospective est destinée à investiguer la mesure peropératoire du débit sanguin dans les 
FAV comme valeur prédictive d'échec précoce. 
Méthode: 
Nous avons sélectionné des patients nécessitant la confection d'une FAV pour hémodialyse en se 
basant sur le repérage veineux effectué par ultrason dans la période préopératoire. La mesure du 
débit sanguin dans la FAV a été réalisée systématiquement après la réalisation de l'anastomose en 
utilisant une sonde mesurant le temps de transit des globules rouges. Durant le suivi, le débit a été 
estimé par ultrason à des intervalles réguliers. 
Résultats: 
Nous avons réalisés 58 FAV chez 58 patients avec un suivi moyen de 30 jours. La thrombose et non 
maturation a été observée chez 8 patients {14%) et 4 patients {7%} respectivement. La valeur de 
débit peropératoire des fistules sans échec précoce était significativement plus élevée que dans les 
fistules avec échec précoce {230 v. 98 ml/min; P = 0.007}, tout comme à une semaine {753 vs 228 
ml/min; P=0.0008} et 4 semaines {915 vs 245 ml/min, P<0.0001). La mesure du débit avec une 
valeur seuil à 120 ml/min présente une sensibilité de 67%, une spécificité de 75% et une valeur 
prédictive positive de 91%. 
Conclusions : 
Un débit sanguin< 120ml/min a une bonne valeur prédictive positive d'échec précoce dans les FAV. 
Durant la procédure, cette valeur seuil, doit être utilisée pour sélectionner de manière appropriée les 
FAV nécessitant durant la même intervention une correction immédiate afin d'améliorer le débit. 
Une étude consécutive devra investiguer les origines des débits faibles des FAV objectivés durant leur 
confection. 
Nephrol Dia! Transplant (2010) 25: 862-867 
doi: 10.1093/ndt/gfp577 
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Abstract 
Background. For over 50 years, radiocephalic wrist arte-
riovenous fistulae (RCAVF) have been the primary and 
best vascular access for haemodialysis. Neve1iheless, early 
failure due to thrombosis or non-maturation is a major 
complication resulting in their abandonment. This pro-
spective study was designed to investigate the predictive 
value of intra-operative blood flow on early failure of pri-
mary RCAVF before the first effective dialysis. 
Methods. We enrolled patients undergoing creation of 
primary RCAVF for haemodialysis based on the pre-
operative ultrasound vascular mapping discussed in a 
multidisciplinary approach. Intra-operative blood flow 
measurement was systematically performed once the anas-
tomosis had been completed using a transit-time ultrasonic 
flowmeter. During the follow-up, blood flow was esti-
mated by colour flow ultrasound at various intervals. 
Any events related to the RCAVF were recorded. 
Results. Autogenous RCAVFs (n = 58) in 58 patients were 
constructed and followed up for an average of 30days. 
Thrombosis and non-maturation occurred in eight (14%) 
and four (7%) patients, respectively. The intra-operative 
blood flow in functioning RCAVFs was significantly high-
er compared to non-functioning RCAVFs (230 vs 98mL/ 
min; P = 0.007), as well as 1 week (753 vs 228mL/min; 
P = 0.0008) and 4weeks (915 vs 245mL/min, P < 
0.0001) later. Blood flow volume measurements with a 
eut-off value of 120mL/min had a sensitivity of 67%, 
specificity of 75% and positive predictive value of 91 %. 
Conclusions. Blood flow <120mL has a good predictive 
value for early failure in RCAVF. During the procedure, 
this eut-off value may be used to select appropriately 
which RCAVF should be investigated in the operation the-
atre in order to correct in real time any abnormality. 
Keywords: autogenous fistula; haemodialysis; maturation; thrombosis; 
vascular access flow 
Introduction 
For over 50years, radiocephalic arteriovenous fistula 
(RCAVF) has demonstrated unquestionable superiority 
over all other types of vascular access for haemodialysis 
[1]. The main benefits of arteriovenous fistula (AVF) are 
better long-term patency and lower complication rate. Nev-
ertheless, failure within the first 4 months after surge1y oc-
curs in 20% to 50% of AVF [1-11]. Early failure of AVF is 
defined as occlusion or insufficient development to sup-
port haemodialysis within the first 3 months [12]. Matura-
tion of an AVF depends on flow volume and diameter of 
the vein used for cannulation. In this regard, Robbin et al. 
showed that the likelihood of sufficient growth was 95% if 
flow volume was 500mL/min or greater in association with 
a diameter of 4mm [13]. In most successful AVF, these 
flow and size parameters are generally met within the first 
few weeks after construction [12]. 
Several pre-operative factors have been shown to predict 
the risk for early AVF failure. The main predictors are the 
diameters of the artery and vein. Pre-operative ultrasound 
(US) mapping is a useful tool for the accurate measure-
ment of vessel diameter as a basis for planning operative 
strategy. Female gender and diabetes may also be risk fac-
tors for early AVF failure. In the scoring system proposed 
by Lok et al. to predict failure to mature of AVF, the four 
main clinical predictors were age over 65, peripheral or 
coronary artery disease and white race [14]. During surgi-
cal exploration, the operator should take into account the 
quality and size of the artery and the vein when deciding 
whether or not to create the fistula at the site chosen during 
pre-operative workup. 
Few studies have evaluated intra-operative factors to 
predict early failure immediately after construction of an 
AVF. Two previous studies evaluated the predictive value 
of intra-operative blood flow volume. Wong et al. were un-
able to demonstrate a link between intra-operative flow 
volume and the risk of early occlusion [1 O]. On the other 
© The Author 2009. Published by Oxford University Press on behalf of ERA-EDTA. Ali rights reserved. 
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hand, Johnson et al. showed that the failure risk was sig-
nificantly higher ifflow volume was less than 170mL/min 
[ 15]. However, none of these studies were specifically 
aimed to assess the value of intra-operative blood flow 
measurements for the outcome of RCAVF. The purpose 
of this study was thus to investigate the value of intra-
operative blood flow measurements in the prediction 
for early failure and/or adequate function of RCAVF in 
a cohort of patients about to start a chronic haemodialy-
sis program in our institution. 
Materials and methods 
Between January 2005 and December 2007, we perfonned 120 first-time 
AVF including 67 RCAV, i.e. 56% of the total number. The study cohort 
included a total of 58 patients that benefited from a first-time RCAVF; 
nine patients were not included due to their previous vascular access by 
central veuous catheter. The criteria for inclusion were indication for ini-
tial haemodialysis requiring first-time AVF and complete follow-up data 
up to the time of the first functioning dialysis. Follow-up was discontin-
ued at the time of the first functioning haemodialysis but never exceeded 
8 weeks. The functioning RCAVF was defined as the ability to use the 
fistula for dialysis with two needles and maintain a dialysis machine 
blood flow rate adequate for optimal dialysis (<!300mL/min) according 
to the Dialysis Consortinm Study (DAC) criteria [16]. During the fol-
low-up, the occlusions and the RCAVF unable to reach DAC's criteria 
were defined as non-functioning. In accordance with our department's fol-
low-up policy for patients undergoing AVF for haemodialysis, ail cases 
were reviewed weekly at multidisciplinary staff meetings attended by 
the nephrologist, angiologist, radiologist, vascular surgeon and dialysis 
nurse. Ail patients underwent a pre-operative vascular mapping by means 
of duplex ultrasound. 
Pre-opera/ive physica/ examina/ion 
The upper limb, shoulder and neck were examined to detect any sign of 
previous trauma, muscle atrophy, verrous hypertension related to proximal 
vein obstruction or chronic ischaemia. Pulses were palpated, and an Allen 
test was performed. Auscnltation was focused on the neck as well as the 
subclavian and axillaiy spaces. 
Pre-operative duplex ultrasound examina/ion 
Duplex US was performed by experienced clinicians from the vascular 
medicine department using 5 to 12 MHz linear transducers (Envisor and 
HD! 5000, Philips Medical Systems Switzerland, Gland, Switzerland; 
Vingmed System V, GE Medical Systems Switzerland, Glattbrugg, Swit-
zerland). The arterial tree was assessed from the clavicle down to the 
wrist. Vesse! diameters and anatomical variations were noted. Spectral 
Doppler waveforms were obtained at different levels. Presence of arterial 
plaque was recorded regardless of whether resulting narrowing was hae-
modynamically significant or not. The extent of diffuse vesse! wall calci-
fication was subjectively evaluated based on the echogenicity of vesse! 
walls and graded as follows: (i) no sign of diffuse calcification; (ii) mild 
calcification causing increased echogenicity ofvessel walls and shadowing 
as observed in the transverse plane; (iii) moderate calcification causing 
not only shadowing but also Doppler attenuation resulting in incomplete 
luminal filling using colour mode; and (iv) severe calcification with high 
echogenicity, marked shadowing and Doppler attenuation causing colour 
to be nearly absent or to fill only very short segments of the artery, show-
ing a patchy pattern. 
The anteroposterior diameters of the superficial veins and distal part 
of the brachial veins were measured in the transverse plane after inflation 
of a pressure cuff positioned as on the arm to 80-90mmHg to interrupt 
verrous return and induce maximal distal vein distension. Thrombosis of 
draining veins was detected by B-mode imaging and compression. Dopp-
ler waveforms of the internai jugular and subclavian or axillary veins 
were analysed. Proximal verrous obstruction was considered as highly un-
likely in patients presenting the following three criteria: Doppler waves in 
both internai jugular and subclavian veins exhibiting clear respiratory and 
cardiac phasicity with the maximal velocity curve crossing the zero line; 
863 
absence of clinicat signs such as distended veins and visible collaterals 
especially around the neck, the shoulder and along the trunk; and normal 
vein compressibility based on subjective assessment using the ultrasound 
probe in B-mode. 
After completing the US examination, findings were used to map the 
anatomical features of vessels including not only course and diameter but 
also the location of any abnormalities (plaque, stenosis and occlusions), 
degree of wall calcification and characteristics of proximal verrous flow. 
Using this map, the clinician proposed the most suitable site for AVF con-
struction. The preferred minimal vein and artery diameters for RCAVF 
creation were 2.5 and 2.0mm, respectively [9]. However, these size pre-
ferences were waived in some cases, e.g. young patients for whom slightly 
smaller vessels were sometimes used and patients with a high degree of 
arterial wall calcification for whom the artery size eut-off value was in-
creased to 3.0mm. 
Surgical technique 
Ail procedures were performed under local or regional anaesthesia using a 
same standardized technique for creation of AVF, i.e. the minimal touch 
technique with limited dissection of the cephalic vein and radial artery. 
The artery was clamped using a coronary artery clamp, and an end-to-side 
anastomosis was made using a continuons 7.0 polypropylene suture. Su-
turing was visualized through magnifying loupes (x3.5). At the operator's 
discretion, papaverine was used after clamp removal if there were signs of 
vasospasm. Systemic or local heparinization was not used. The patients 
were operated on by a single vascular surgeon or senior resident super-
vised by this surgeon. 
lntra-operative measurement (){ b/ood jlow volume 
lntra-operative measurement of blood flow volume was systematically 
performed immediately after the construction of the AVF. In the case of 
vasospasm requiring the use of papaverine, the measurement was delayed 
for 5min. Measurements were performed by placing a 3--4mm handheld 
flowprobe (MediStim, Oslo, Norway) around the draining vein 2cm 
downstream from the anastomosis. Direct readings in rnL/min were re-
corded after stabilization for 30 s. At least three readings were made until 
consistent values were obtained usually within the first 5 min. Systolic 
and diastolic pressure was recorded concomitantly with flow volume 
measurements. Ali data were consigned to a dedicated study form imme-
diately after the procedure. 
Post-opera/ive ultrasound 
Post-operative US was performed at each follow-up examination at 1 
week, 1 month and jnst prior to the first RCAVF cannulation. Blood flow 
was assessed by measuring mean flow velocity and luminal diameter in 
separate segments of brachial, ulnar, pre-anastomotic and post-anastomot-
ic radial arteries. Spectral Doppler and mean velocity were obtained with 
a Doppler angle at 60° and a sample size covering the entire lumen. Ac-
cess blood flow was then calculated by adding pre-anastomotic radial to 
post-anastomotic radial flow, in case of retrograde flow in the latter. If 
post-anastomotic radial flow was antegrade, it was subtracted from pre-
anastomotic flow. During Doppler sonography, blood pressure was re-
corded several times on the controlateral arm by means of an automated 
oscillometric manometer. 
After access blood flow detennination, feeding arteries and draining 
veins as well as the anastomosis were checked for the presence of steno-
ses. First, a colour Doppler scan of arteries from the clavicle down to the 
anastomosis was performed while analysing any flow disturbance by 
spectral Doppler to obtain peak systolic velocity. The same was done 
for the veins, from the anastomosis up to the clavicle and internai jugular 
vein. Then, a precise B-mode image of each stenosis detected by colour 
Doppler was obtained, and minimal luminal diameter was measured. 
Study results were consigned to a dedicated form indicating access flow, 
mean systolic and diastolic blood pressures and a vascular map of the 
entire limb showing flow direction, vesse! diameters and any stenosis with 
its peak systolic velocity and minimal luminal diameter. 
Statistical analysis 
Statistical analysis was performed using Stata version 9.2 (StataCorp, Col-
lege Station, TX, USA). Results were expressed either as number of pa-
tients (percentage) or as mean (± standard deviation). Between-group 
864 
Table 1. Demographic features, comorbidities, surgical findings and 
vesse] diameters in 58 patients who underwent first-time RCAVF 
Variable Number (%)/mean ± SD 
Age (year) 63 ± 14.3 
Gender 
Male 40 (69) 
Female 18 (31) 
Medical history 
Hypertension 39 (67) 
Dia be tes 33 (57) 
Current smoker 7 (12) 
Ischaemic cardiac disease 18 (31) 
Peripheral vascular disease 12 (20) 
Anticoagulation 15 (25) 
Antiaggregation 30 (51) 
Intra-operative data 
Intra-operative BF (mL/min) 203 ± 182 
Artery diameter (mm) 2.9 ± 0.6 
Vein diameter (mm) 3.1±0.6 
SBP (mmHg) 133 ± 24 
DBP (mmHg) 76 ± 13 
Papaverine 13 (22) 
Left arm 38 (66) 
BF, blood flow; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
Continuous variables are presented as mean ±standard deviation (SD) and 
discrete variables as number with (percentage ). 
comparisons were performed using the Wilcoxon test for quantitative data 
and Fisher's exact test for qualitative data. Threshold values were screened 
using the roctg function of Stata with 25 mL/min blood flow volume in-
tervals. Specificity, sensitivity and predictive values were computed to-
gether with the respective 95% confidence intervals using the diatg 
function of Stata. A P value Jess than 0.05 was considered as statistically 
significant. 
Results 
Patient data including demographic characteristics, surgi-
cal findings, vesse! diameters and comorbid conditions 
are presented in Table 1. The mean age of patients was 
63 ± 14.3years with 38% over the age of 70years. 
The mean duration of follow-up was 30days (range, 15 
to 45 days; median, 21 days ). During follow-up, one patient 
(1.7%) died at home from causes unrelated to the RCAVF, 
and 12 patients (20.6%) presented events related to the 
RCAVF, i.e. either failure to mature in four cases or perma-
nent occlusion in eight cases. Ali eight occlusions occurred 
within the first post-operative week (mean delay, 3.3 days; 
range, 1-6days). In ail cases, alternative vascular access 
sites were created in more proximal locations including ip-
silateral brachiocephalic AVF in 63% and placement of a 
prosthetic loop on the forearm in 37%. Placement of a per-
manent dialysis catheter was necessary in four of the eight 
patients (50%) with inadequate RCAVF. 
Table 2 compares patients who presented no events with 
patients who presented early failure due to occlusion or 
failure to mature. Female gender and low intra-operative 
flow volume were significantly associated with early fail-
ure. To gain further insight on the impact offemale gender, 
the overall data were compared by gender (Table 3). Find-
ings showed that the artery diameter was significantly 
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Table 2. Comparison of demographic features, surgical findings, vesse] 
diameters and comorbid conditions in 58 patients with non-functioning 
(n = 12) and functioning (11 = 46) RCAVF 
Non-functioning Functioning 
Variable RCAVF RCAVF P value 
Il 12 46 
Age (years) 57.5 ± 16.5 64.4 ± 13.5 0.12 
Female gender 7 (58) 11 (24) 0.03 
Medical history 
Hypertension 10 (83) 29 (63) 0.3 
Diabetes 10 (83) 23 (50) 0.06 
lschaemic cardiac disease 3 (25) 12 (26) 0.94 
Peripheral vascular disease 3 (25) 9 (19) 0.68 
Anticoagulation 4 (33) 11 (23) 0.51 
Antiaggregation 8 (26) 22 (47) 0.25 
Current smoker 1 (8) 6 (13) 0.1 
Pre-operative data 
Artery diameter (mm) 2.8 ± 0.6 2.9 ± 0.6 0.58 
Vein diameter (mm) 2.9 ± 0.6 3.2 ± 0.8 0.21 
Arterial calcification 5 (18) 12 (46) 0.83 
Intra-operative data 
BF (mL/min) 98 ± 65 230 ± 194 0.007 
SBP (mmHg) 134 ± 25 137 ± 25 0.82 
DBP (mmHg) 75 ± 13 78 ± 13 0.86 
Other 
Papaverine 3 (25) IO (22) 1.00 
Left ann 6 (50) 32 (70) 0.31 
Local anaesthesia 13 (72) 32 (69) 0.51 
BF, blood flow; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
smaller in women than men: 2.6±0.5 vs 3.0±0.6mm, re-
spectively (P = 0.03). The post-operative blood flow after 
4weeks was also statistically higher in men (P = 0.02). 
Vesse! wall calcifications were identified in three patients 
(16%) in the non-functioning RCAVF and six (15%) in the 
functioning RCAVF group. 
Flow measurements in ail patent RCAVF at 1 month af-
ter the creation demonstrated a mean flow volume of733± 
296 mL/min, i.e. a mean increase of 261 % in comparison 
with intra-operative findings. Figure 1 shows that during 
the first post-operative month, the non-functioning 
RCAVF flow volume only increased by 142% from 101± 
87 to 245 ±412 mL/min, whereas blood flow of functioning 
RCAVF demonstrated an increase of294% from 232 ± 194 
to 915 ± 3 53 mL/min. The increase ofblood flow developed 
mainly during the first post-operative week. Indeed, in the 
functioning RCAVF, the blood flow increased by 224% 
from 232 ± 194 to 753 ± 269mL/min, and only by 125% 
from Weeks 1 to 4. These kinetics also occurred in the non-
functioning RCAVF with an increase of 21 % during the 
first post-operative week and only 7% from Weeks 1 to 4. 
Further analysis of flow volume data showed that the most 
sensitive eut-off value to discriminate functioning and 
non-functioning RCAVF was 120mL/min. Nine of the 
12 non-functioning RCAVF (75%) presented flow vo-
lumes less than 120mL/min as compared to only 15 of 
the 46 (32%) functioning RCAVF. A flow volume greater 
than 120mL/min exhibited good sensitivity and specificity, 
i.e. 67.4% (range, 51.9-80.5%) and 75% (range, 42.8-
94.5% ), respectively. The positive predictive value of this 
parameter was 91.2%, i.e. excellent (range, 76.3-98.l %). 
The negative predictive value was, however, only 37.5% 
(range; 18.8-59.4%). 
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Table 3. Comparison of demographic featnres, comorbidities, surgical 
findings and vesse! diameters in men (n = 40) and women (n = 18) 
Women Men P value 
Il 18 40 
Age (years) 63.7 ± 17.3 62.6 ± 13 0.48 
Medical history 
Dia be tes 11 (61) 22 (55) 0.78 
Hypertension 13 (72) 26 (65) 0.76 
Ischaemic cardiac disease 6 (33) 12 (30) 0.80 
Peripheral vascular disease 4 (22) 8 (20) 0.85 
Current smoker 2 (25) 5 (12) 0.88 
Anticoagulation 5 (27) 10 (40) 0.82 
Antiaggregation 9 (50) 21 (52) 0.86 
Blood Flow 
Intra-operative BF (mL/min) 142.7 ± 94.7 230.2 ± 205.6 0.13 
Post-operative BF (mL/min) 513.6 ± 330.2 784. 7 ± 278. 9 0.02 
Pre-operative diameter 
Artery diameter (mm) 2.6 ± 0.5 3.0 ± 0.6 0.03 
Vein diameter (mm) 3.1±0.7 3.1±1.0 0.99 
Other 
Papaverin 5 (27) 8 (20) 0.52 
Left arm 11 (61) 27 (67) 0.77 
BF, blood flow. Results are expressed as mean ± standard deviation or as 
number of subjects and (percentage). Statistical analysis by Wilcoxon test 
or Fisher's exact test. 
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Fig. 1. Blood flow (in mL/min) in functioning (black box) and non-
functioning RCAVF (white box). 
Discussion 
Our findings demonstrate that the intra-operative measure-
ment of blood flow immediately after construction of a 
RCAVF was useful to predict early AVF failure. Statistical 
analysis identified a eut-off value of 120mL/min for dis-
criminating functioning and non-functioning RCAVF. 
Johnson et al. reported that a high intra-operative flow vol-
ume defined as 320mL/min or greater was associated with 
a lower number of surgi cal revisions and longer access sur-
vival regardless of gender, race or presence of diabetes. 
The same authors reported that an intra-operative flow rate 
of Jess than l 70mL/min was correlated with a 56% risk for 
AVF failure within the first 50days after construction [15]. 
In their 50-patient series, Won et al. also showed that an 
intra-operative flow rate of Jess than 160 mL/min was pre-
dictive of early failure of RCAVF [ 17]. A recent study in-
cluding a cohort of 109 patients undergoing vascular 
865 
access surgery for first-time haemodialysis showed that 
an intra-operative flow rate greater than 200mL/min was 
associated with better middle-term outcome in terms of re-
quirement for revision and early patency rate [18]. 
In this study, follow-up was limited to the period imme-
diately after construction of the RCAVF up to the first hae-
modialysis. The goal was to eliminate the effect of 
puncture trauma associated with repeated puncture for ve-
nous access. This trauma may cause stenosis and/or hae-
morrhagic complications that are probably detrimental to 
AVF patency. Previous authors reported longer follow-up 
than ours but could not rule out the confounding effect of 
haemodialysis-related injury on their results. Moreover, 
the period prior to dialysis is crucial for AVF development 
that appears to be correlated with flow volume. Immedi-
ately after AVF construction, flow volume increases rapid-
ly, reaching a maximum within 4 to 12weeks [10,19-22]. 
Between 40% and 60% of the total increase in flow vol-
ume occurs within 24h after creation of the AVF 
[10,19-22]. For most fistulas located on the forearm, max-
imum flow volume is reached within 4weeks after con-
struction [ 10, 19]. The rate of the flow volume increase 
depends partly on the diameter of the vein lumen. In an 
earlier report, our group studied the size of the draining 
vein and observed that the lumen increased 86% after 1 
week and 179% after 12weeks in comparison with the lu-
men of the contralateral vein [22]. These results confomed 
a previous study involving AVF located on the forearm 
that showed a 56% increase within the first 24h after con-
struction to 123 % at 12 weeks in comparison with con trois 
[10]. A fistula can be considered as mature or suitable to 
support haemodialysis when it allows insertion oftwo nee-
dles and can provide sufficient blood flow, i.e. at least 
350-450mL/min. Adequate flow volume is at least of 
500mL/min for an AVF [23]. There is currently no con-
sensus as to criteria for predicting the outcome of AVF de-
velopment. Sorne authors wait as long as 3 to 4months 
before declaring an AVF non-functioning [16,24]. 
Several studies have attempted to identify predictors of 
AVF development. Pre-operative vascular mapping that we 
have been using routinely for many years has been shown 
to maximize the opportunities for autogenous fistulas and 
lower the need for prosthetic fistulas [9,25]. However, a 
reliable correlation has not been established between pre-
operative evidence of adequate artery and vein diameter 
and AVF development [10,26,27]. A recent study [28] in-
dicated that measurement of vein compliance was a good 
predictor of AVF development, but this finding was not 
confirmed in two subsequent studies [21,29]. Post-opera-
tive measurement ofblood flow volume by duplex US has 
not been consistently shown to be useful in predicting AVF 
development [30,31]. Our data showed that the increase in 
flow volume during the first month after creation was 
261 % for functioning RCAVF as compared to only 
142% for non-functioning RCAVF. This finding suggests 
that there is a good correlation between rapid flow volume 
increase in the first post-operative month and maturation 
of the RCAVF. Intra-operative and post-operative measure-
ments showed that mean blood flow volume was signifi-
cantly higher in functioning than non-functioning RCAVF. 
The intra-operative measurement of arterial dilation in re-
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sponse to reactive hyperaemia has also been identified as a 
predictor for AVF development with a sensitivity of 95%, 
a specificity of 61 % and a positive predictive value of 
87% [29]. In comparison, our results indicated that blood 
flow volume measurements with a cut-offpoint of 120mL/ 
min had a sensitivity of 67%, specificity of 75% and pos-
itive predictive value of 91 %. 
In agreement with previous studies [32,33], our data also 
showed that failure of an RCAVF to mature was frequently 
associated with females. Comparison of vesse! diameters 
according to gender in our cohort demonstrated that arter-
ies were significantly smaller in women than in men. 
However, it should be underlined that our findings are in 
contradiction with two recent studies showing no signifi-
cant gender difference in the pre-operative diameters of 
veins and arteries [32,34]. 
Failure of an AVF to mature can have many aetiologies 
[35]. The most frequent cause is neointimal hyperplasia 
typically occurring in the juxta-anastomotic vein. Hyper-
plasia develops during the first post-operative month. In 
our study, ail AVF occlusion occurred during the first 
post-operative week. Possible explanations include a defect 
in the surgical technique, poor vein quality or insufficient 
vesse! diameter that was incorrectly estimated during US 
mapping. Pre-operative measurements should be made to 
detect possible sources of insufficient flow volume. US 
mapping could also decrease the functional maturation 
rate by the increase in performing complex procedures 
which were often secondary ones and by the use of smaller 
vein only detected by US but invisible during upper limb 
inspection [36]. Our vascular access improvement pro-
gram provides for increasing the rate of autogenous vascu-
lar access and decreasing early failure. Pre-operative US 
mapping, early referral to vascular surgeon and surveil-
lance program are some of the measures to achieve these 
goals. Despite the implementation of the Disease Out-
comes Quality Initiative (DOQI) guidelines in our institu-
tion, 12 (20%) RCAVF failed to mature or occluded. The 
intra-operative surgi cal assessment of the vessels is the last 
possibility to choose the right strategy. To detect technical 
defects and identify poor artery or vein quality, Lin et al. 
proposed performing fistulography during the same proce-
dure. The same authors pointed out that if a technical de-
fect requiring surgical correction was not found, careful 
post-operative surveillance was necessary to allow early 
detection and prompt treatment of possible problems. 
They also proposed immediate construction of another 
fistula in diabetic patients presenting intra-operative flow 
volume less than 200mL/min [18]. Finally, Berman et al. 
recommended that RCAVF with an intra-operative flow 
rate of <120mL/min should either be immediately aban-
doned for another site or, at a minimum, evaluated for 
an immediate revision [37]. In view of these results, we 
intend to find out whether intra-operative haemodynamic 
and anatomical criteria may directly impact on the deci-
sion-making process in patients awaiting a functional AVF. 
Our study may have a direct implication for practical 
clinical issue. Indeed, the intra-operative blood flow mea-
surement should be carried out after each procedure to get 
a start value. A blood flow <120mL/min has a good pre-
dictive value of early failure. This implies that we should 
F. Saucy et al. 
aim for intra-operative investigations in order to look for a 
possible reason for this low blood flow. For instance, a fis-
tulography with potentially a subsequent interventional 
procedure to re-establish a higher blood flow may be pro-
posed. This hypothesis will be tested in a further study in 
our institution. In contrast, an intra-operative blood flow 
> 120 ml/min may be interpreted as a safe result in terms 
of future RCAVF maturation. In conclusion, the findings 
of this study indicated that the intra-operative measure-
ment of blood flow is a useful tool to predict the outcome 
of maturation in first-time RCAVF. A simple transit-time 
device can be used to obtain immediate readings that can 
be used to adapt operative strategy and thus improve out-
come. These findings should be associated with blood flow 
value measurement just before the first puncture which is 
obviously an important criterion for making a decision. 
Whether this can be used to modify the intra-operative 
strategy, thus reducing the failure-to-mature rate, needs to 
be investigated. 
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Abstract 
Background. In children, growth can be used as a measur-
able parameter of adequate nutrition and dialysis dose. De-
spite daily administration of recombinant human growth 
hormone (rhGH), growth retardation remains a frequent 
problem in children on chronic dialysis. Therefore, we per-
formed an observational prospective non-randomized study 
of children on in-centre daily on line haemodiafiltration (D-
OL-HDF) dialysis with the aim ofpromoting growth. 
Patients and methods. Mean age at the start of the study 
was 8 years and 3 months, and ail children had been receiv-
ing rhGH treatment for> 12 months before enrolment. Mean 
follow-up time on D-OL-HDF was 20.5 ± 8 months (range, 
11-39 months). Rena! residual function was either <3 mL/ 
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